Lexeo Therapeutics, Inc./$LXEO
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Lexeo Therapeutics, Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.
Ticker
$LXEO
Sector
Primary listing
Employees
61
Headquarters
Website
LXEO Metrics
BasicAdvanced
$720M
-
-$2.45
1.78
-
Price and volume
Market cap
$720M
Beta
1.78
52-week high
$10.38
52-week low
$1.45
Average daily volume
1.4M
Financial strength
Current ratio
7.399
Quick ratio
7.108
Long term debt to equity
4.752
Total debt to equity
6.999
Interest coverage (TTM)
-1,081.17%
Profitability
EBITDA (TTM)
-112.933
Management effectiveness
Return on assets (TTM)
-44.66%
Return on equity (TTM)
-80.69%
Valuation
Price to book
4.48
Price to tangible book (TTM)
4.48
Price to free cash flow (TTM)
-3.934
Free cash flow yield (TTM)
-25.42%
Free cash flow per share (TTM)
-2.507
Growth
Earnings per share change (TTM)
-21.61%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Lexeo Therapeutics, Inc. stock?
Lexeo Therapeutics, Inc. (LXEO) has a market cap of $720M as of December 02, 2025.
What is the P/E ratio for Lexeo Therapeutics, Inc. stock?
The price to earnings (P/E) ratio for Lexeo Therapeutics, Inc. (LXEO) stock is 0 as of December 02, 2025.
Does Lexeo Therapeutics, Inc. stock pay dividends?
No, Lexeo Therapeutics, Inc. (LXEO) stock does not pay dividends to its shareholders as of December 02, 2025.
When is the next Lexeo Therapeutics, Inc. dividend payment date?
Lexeo Therapeutics, Inc. (LXEO) stock does not pay dividends to its shareholders.
What is the beta indicator for Lexeo Therapeutics, Inc.?
Lexeo Therapeutics, Inc. (LXEO) has a beta rating of 1.78. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.